ES2178111T3 - Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno. - Google Patents

Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno.

Info

Publication number
ES2178111T3
ES2178111T3 ES98303055T ES98303055T ES2178111T3 ES 2178111 T3 ES2178111 T3 ES 2178111T3 ES 98303055 T ES98303055 T ES 98303055T ES 98303055 T ES98303055 T ES 98303055T ES 2178111 T3 ES2178111 T3 ES 2178111T3
Authority
ES
Spain
Prior art keywords
arilbenzo
aroil
thiophene compound
fibrinogen levels
reduce fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98303055T
Other languages
English (en)
Inventor
Pamela Wang Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2178111T3 publication Critical patent/ES2178111T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

LA INVENCION SE REFIERE A LA REDUCCION DE FIBRINOGENO EN HUMANOS, MEDIANTE LA ADMINISTRACION DE UN COMPUESTO DE 2 - AROIL - 3 - ARILBENZO[B]TIOFENO.
ES98303055T 1997-04-22 1998-04-21 Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno. Expired - Lifetime ES2178111T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22

Publications (1)

Publication Number Publication Date
ES2178111T3 true ES2178111T3 (es) 2002-12-16

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98303055T Expired - Lifetime ES2178111T3 (es) 1997-04-22 1998-04-21 Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno.

Country Status (23)

Country Link
US (1) US6025373A (es)
EP (1) EP0878195B1 (es)
JP (1) JP2001524101A (es)
KR (1) KR20010012084A (es)
CN (1) CN1254255A (es)
AT (1) ATE219364T1 (es)
AU (1) AU741720B2 (es)
BR (1) BR9809286A (es)
CA (1) CA2287196A1 (es)
DE (1) DE69806098T2 (es)
DK (1) DK0878195T3 (es)
EA (1) EA002237B1 (es)
ES (1) ES2178111T3 (es)
HU (1) HUP0002727A3 (es)
ID (1) ID22910A (es)
IL (1) IL132504A0 (es)
NO (1) NO995132L (es)
NZ (1) NZ500389A (es)
PL (1) PL336638A1 (es)
PT (1) PT878195E (es)
TR (1) TR199902605T2 (es)
WO (1) WO1998047365A1 (es)
ZA (1) ZA983298B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
CA2126227C (en) * 1991-12-17 2001-10-23 Eduard Emmanuilovich Godik Method of living system organism diagnostics and apparatus for its realization
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
ATE220323T1 (de) * 1993-10-15 2002-07-15 Lilly Co Eli Methode zur behandlung von resistenten neoplasmen
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
EP0724879A2 (en) * 1995-02-06 1996-08-07 Eli Lilly And Company 2-Phenyl-3-azoylbenzothiopenes for inhibiting effects of IL-6
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
HUP0002727A3 (en) 2001-09-28
NO995132D0 (no) 1999-10-21
HUP0002727A2 (hu) 2001-08-28
CA2287196A1 (en) 1998-10-29
ATE219364T1 (de) 2002-07-15
TR199902605T2 (xx) 2000-02-21
BR9809286A (pt) 2000-07-04
DE69806098T2 (de) 2003-01-02
AU7250398A (en) 1998-11-13
PT878195E (pt) 2002-09-30
DE69806098D1 (de) 2002-07-25
ID22910A (id) 1999-12-16
NO995132L (no) 1999-10-21
AU741720B2 (en) 2001-12-06
EP0878195B1 (en) 2002-06-19
EA002237B1 (ru) 2002-02-28
EA199900959A1 (ru) 2000-06-26
PL336638A1 (en) 2000-07-03
JP2001524101A (ja) 2001-11-27
EP0878195A1 (en) 1998-11-18
IL132504A0 (en) 2001-03-19
ZA983298B (en) 1999-10-20
WO1998047365A1 (en) 1998-10-29
KR20010012084A (ko) 2001-02-15
US6025373A (en) 2000-02-15
CN1254255A (zh) 2000-05-24
NZ500389A (en) 2001-07-27
DK0878195T3 (da) 2002-07-15
MX9909548A (es) 2003-02-27

Similar Documents

Publication Publication Date Title
HRP20030472B1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
ES2192708T3 (es) Combinaciones de productos activos fungicidas.
TR200000782T2 (tr) Resorsinol türevleri.
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
ATE249206T1 (de) Langwirkende, injizierbare, formulierungen enthaltend rizinusöl
HN1998000132A (es) Combinaciones terapeuticas
EA199800645A1 (ru) Фунгицидные 2-метоксибензофеноны
HN1998000057A (es) Derivados de nicotinamida
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
PT1193270E (pt) Pirrolobenzodiazepinas
HN1998000036A (es) Compuesto de pirazina
HN1998003689A (es) Azetidinas
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
BR9913389B1 (pt) agentes de preparaÇço, bem como precesso para sua preparaÇço.
HN1998000045A (es) Composiciones farmaceuticas
ES2178111T3 (es) Uso de un compuesto 2-aroil-3-arilbenzo(b)tiofeno para rebajar los niveles de fibrinogeno.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
ITRM950143V0 (it) Fermo per evitare la dilatazione di contenitori comprimibili, dopo la loro compressione.
FI933506A0 (fi) Bicyklopolyazamakrocyklokarboxylsyrakomplex, konjugat daerav, foerfarande foer deras framstaellning och anvaendning som kontrastmedel